openPR Logo
Press release

Huge Investment in Cardiac Arrest Treatment Market Expected to Witness the Highest Growth 2025 | GE, J&J, Abbott, Amgen, Pfizer, Novartis, Bristol-Myers Squibb, Boston Scientific, Bayer

04-01-2020 05:49 AM CET | Health & Medicine

Press release from: Business Industry Reports

Cardiac Arrest Treatment Market

Cardiac Arrest Treatment Market

Global Cardiac Arrest Treatment Market Synopsis:

The report covers a forecast and an analysis of the Cardiac Arrest Treatment Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Cardiac Arrest Treatment Market along with the impact they have on the demand over the forecast period.

Some of the most important key factors driving the growth of the Global Cardiac Arrest Treatment Market are rapid growth in cardiovascular diseases, increasing sedentary lifestyle, rising the geriatric population and the presence of research activities. As per the World Health Organization (WHO), around 17.9 million people die of cardiovascular diseases, every year, an estimated 31% of all the deaths worldwide. Four out of five CVD deaths are due to heart attacks and strokes. According to the World Journal of Cardiovascular Diseases, more than 7 million deaths are due to the sudden cardiac arrest across the globe each year. Thus, the growing number of heart failures, heart attacks, strokes, and other heart-related illness are driving the growth of Global Cardiac Arrest Treatment Market.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/252280 .

In terms of the regional analysis, the North America is dominating the Global Cardiac Arrest Treatment Market in 2018 and is estimated to hold significant market size over the forecast period (2020-2025) owing to the high adoption rate of CRT for cardiac arrest treatment among cardiologists and heart specialists and the presence of a large number of AED centers. Growing incidence of cardiovascular disorders and the advancements in medical devices for the treatment of cardiac arrest are expected to boost the market.

This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global Cardiac Arrest Treatment Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

Global Key Players:

1 Amgen

2 Pfizer

3 Johnson & Johnson

4 Novartis AG

5 Bristol-Myers Squibb Company

6 Abbott

7 Koninklijke Philips

8 GE Healthcare

9 Physio-Control, Inc.

10 Boston Scientific Corporation

11 Cardiac Science Corporation

12 Shenzhen Mindray Bio-Medical Electronics

13 Bayer AG and More..............

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Cardiac Arrest Treatment Market Report 2020" @ https://www.businessindustryreports.com/buy-now/252280/single .

Product Type Segmentation

1 Drugs

2 Medical

Industry Segmentation

1 Hospitals

2 Independent Pharmacies

On the basis of Regional analysis, North America and Europe holds major share in global Cardiac Arrest Treatment market. Moreover, Asia-Pacific is expected to record higher growth rate in Cardiac Arrest Treatment Market during the forecast year.

Global Medical Industry News:

Abbott (March 27, 2020) - Abbott Launches Molecular Point-Of-Care Test to Detect Novel Coronavirus in As Little As Five Minutes - Abbott announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOW platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics and hospital emergency departments.

The ID NOW platform is small, lightweight (6.6 pounds) and portable (the size of a small toaster), and uses molecular technology, which is valued by clinicians and the scientific community for its high degree of accuracy. ID NOW is already the most widely available molecular point-of-care testing platform in the U.S. today.

"The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus," said Robert B. Ford, president and chief operating officer, Abbott. "With rapid testing on ID NOW, healthcare providers can perform molecular point-of-care testing outside the traditional four walls of a hospital in outbreak hotspots."

Abbott will be making ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the U.S., where the majority of ID NOW instruments are in use today. The company is working with the Administration to deploy tests to areas where they can have the greatest impact.

The arrival of the Abbott ID NOW COVID-19 test comes a week after the company launched its Abbott m2000 RealTime SARS-CoV-2 EUA test, which runs on the m2000 RealTime System located in hospital and reference labs around the world. Between the two platforms, Abbott expects to produce about 5 million tests per month.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/252280 .

Major Points in Table of Contents:

Global Cardiac Arrest Treatment Market Report 2020

1 Cardiac Arrest Treatment Product Definition

2 Global Cardiac Arrest Treatment Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Cardiac Arrest Treatment Shipments

2.2 Global Manufacturer Cardiac Arrest Treatment Business Revenue

2.3 Global Cardiac Arrest Treatment Market Overview

3 Manufacturer Cardiac Arrest Treatment Business Introduction

3.1 Amgen, Inc. Cardiac Arrest Treatment Business Introduction

3.2 Pfizer, Inc. Cardiac Arrest Treatment Business Introduction

3.3 Johnson & Johnson Cardiac Arrest Treatment Business Introduction

3.4 Novartis AG Cardiac Arrest Treatment Business Introduction

3.5 Bristol-Myers Squibb Company Cardiac Arrest Treatment Business Introduction

3.6 Abbott Cardiac Arrest Treatment Business Introduction

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Huge Investment in Cardiac Arrest Treatment Market Expected to Witness the Highest Growth 2025 | GE, J&J, Abbott, Amgen, Pfizer, Novartis, Bristol-Myers Squibb, Boston Scientific, Bayer here

News-ID: 1993791 • Views: 294

More Releases from Business Industry Reports

Cold and Flu Drugs Market Will Hit Big Revenues In Future | Biggest Opportunity …
The Cold and Flu Drugs market 2020 report analyses global acceptance of trends, future growth potential, key drivers, limitations, opportunities, and best practices that are taken place in market. The report also examines growth potential, market sizes and revenue forecasts (2020-2025)across different regions as well as industry verticals. Global Cold and Flu Drugs Market Overview: This Cold and Flu Drugs market study offers a comprehensive analysis of the business models, key strategies,
Tripropargylamine Market Widely Growing Worldwide by Forecast 2020-2025 | Top Ve …
Global Tripropargylamine Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players in the market. This research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. Global Tripropargylamine Market overview: Tripropargylamine is widely used in the synthesis of Cu(I) stabilizing ligands such as tris(3-hydroxypropyltriazolylmethyl)amine (THPTA) and tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) for the copper-catalyzed alkyne-azide cycloaddition
Reinsurance Market Will Be Massively Influenced By Macroeconomic Factors 2020-20 …
The demand for Reinsurance Market 2020 is anticipated to be high for the next few years. By considering this demand we provide latest Reinsurance Market Report which gives complete industry analysis, market outlook, size, growth and forecast till 2025. This report will assist in analyzing the current and future business trends, sales and revenue forecasts. Global Reinsurance Market Overview: The Global Reinsurance Market has also suffered a certain impact, but still maintained
Innovative Report on CBD Hemp Oil Market with New Business Developments and Top …
Global CBD Hemp Oil Market Synopsis: The exclusive research report on the Global CBD Hemp Oil Market 2020-2025 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global CBD Hemp Oil Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe. The Global CBD Hemp Oil Market has also suffered

All 5 Releases


More Releases for Cardiac

Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Ambulatory Cardiac Monitoring Devices
Ambulatory Cardiac Monitoring Devices Market by Product (Ambulatory Rhythm Monitor, Ambulatory ECG Monitor, Ambulatory Cardiac Event Monitor, Implantable Loop Recorder, Ambulatory real-time Cardiac Monitors, Cardiac Output Monitors); by End-User (Hospitals, Ambulatory Care Centers); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) –
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025   Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are